Impact of dose and duration of corticosteroid on the risk of hepatitis flare in patients with chronic hepatitis B.

Grace Lai-Hung WongBecky Wing-Yan YuenHenry Lik-Yuen ChanYee-Kit TseTerry Cheuk-Fung YipKelvin Long-Yan LamGrace Chung-Yan LuiVincent Wai-Sun Wong

Published in: Liver international : official journal of the International Association for the Study of the Liver (2018)

Even short courses of high-dose corticosteroid increase the risk of hepatitis flare in CHB patients. Patients receiving high-dose corticosteroid should be considered for antiviral prophylaxis regardless of the duration of treatment.

Keyphrases

high dose
end stage renal disease
low dose
stem cell transplantation
ejection fraction
newly diagnosed
chronic kidney disease
hepatitis b virus
peritoneal dialysis
prognostic factors
combination therapy
liver fibrosis
smoking cessation